Status:
COMPLETED
Treatment, Pain, and Opioids
Lead Sponsor:
VA Office of Research and Development
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Chronic pain and negative consequences of long-term opioid therapy are related public health concerns associated with significant functional impairment, high psychiatric comorbidity, and p...
Eligibility Criteria
Inclusion
- Participants will include English-speaking Veterans on long-term opioid therapy prescribed opioid analgesics (\>20mg morphine equivalent daily \[MEDD\] and at least a 90 days supply).
- Participants must report pain that occurs on at least half the days for six months.
- They must score at least a 4 on each item of the three items on a brief pain intensity and interference measure.
Exclusion
- Veterans will be excluded if they are currently undergoing oncology treatment, are hospice patients, and have a recent or upcoming surgery.
- Veterans will be excluded if they are currently engaged (i.e., within the past month) in non-pharmacological pain treatment.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05363176
Start Date
June 1 2022
End Date
March 25 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Finger Lakes Healthcare System, Canandaigua, NY
Canandaigua, New York, United States, 14424-1159